ClinicalTrials.Veeva

Menu

Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct

U

University of Sao Paulo

Status

Unknown

Conditions

Neuromyelitis Optica
Multiple Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT01024985
0190/09

Details and patient eligibility

About

The purpose of this study is to determine the ability of STRATUS OCT and high resolution OCT to detect and to quantify the neural loss in multiple sclerosis and neuromyelitis optica and its subtypes.

Enrollment

40 estimated patients

Sex

All

Ages

15 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of multiple sclerosis or neuromyelitis optica
  • age between 15 and 60 years
  • BCVA better than 20/400
  • no optic neuritis crisis in the last 6 months

Exclusion criteria

  • diagnosis of glaucoma, opacities or disc anomalies
  • diagnosis of macular disease
  • disc swelling at fundoscopy

Trial design

40 participants in 3 patient groups

multiple sclerosis
neuromyelitis optica
controls

Trial contacts and locations

1

Loading...

Central trial contact

mario luiz r monteiro, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems